{
    "clinical_study": {
        "@rank": "129649", 
        "brief_summary": {
            "textblock": "To evaluate the safety and effectiveness of fluconazole as an intravenous dose as initial\n      treatment for acute cryptococcal meningitis followed by oral therapy in AIDS and non-AIDS\n      patients. Lack of satisfactory response will allow increase of dose. Both newly diagnosed\n      and relapsed patients are eligible."
        }, 
        "brief_title": "An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis", 
        "condition": [
            "Meningitis, Cryptococcal", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Meningitis", 
                "Meningitis, Cryptococcal"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Antivirals such as zidovudine (AZT).\n\n          -  Prophylaxis for Pneumocystis carinii pneumonia (including aerosolized pentamidine).\n\n        Concurrent Treatment:\n\n        Allowed:\n\n          -  Radiation therapy for mucocutaneous Kaposi's sarcoma.\n\n        Written informed consent must be obtained for each patient, either from the patient\n        himself or from the patient's legal guardian.\n\n          -  Patient's treatment status must be one of the following:\n\n          -  No prior systemic antifungal therapy for cryptococcosis.\n\n          -  Relapse after prior therapy. The success of prior therapy must have been documented\n             by negative CSF culture at the end of therapy. Following prior therapy, such patients\n             may not have received more than 1 mg/kg/wk amphotericin B in the 4 weeks before entry\n             into the study.\n\n        Prior Medication:\n\n        Allowed:\n\n          -  Antivirals such as zidovudine (AZT).\n\n          -  Prophylaxis for Pneumocystis carinii pneumonia (including aerosolized pentamidine).\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following are excluded:\n\n          -  Evidence of acute or chronic meningitis based upon any etiology other than\n             cryptococcosis.\n\n          -  A history of allergy to or intolerance of imidazoles or azoles.\n\n          -  Moderate or severe liver disease defined by specified lab values.\n\n          -  Life expectancy of < 2 weeks.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Coumarin-type anticoagulants.\n\n          -  Oral hypoglycemics.\n\n          -  Barbiturates.\n\n          -  Phenytoin.\n\n          -  Immunostimulants.\n\n          -  Investigational drugs or approved (licensed) drugs for investigational indications\n             other than aerosolized pentamidine.\n\n        Concurrent Treatment:\n\n        Excluded:\n\n          -  Lymphocyte replacement.\n\n        Patients with the following are excluded:\n\n          -  Evidence of acute or chronic meningitis based upon any etiology other than\n             cryptococcosis.\n\n          -  A history of allergy to or intolerance of imidazoles or azoles.\n\n          -  Moderate or severe liver disease defined by specified lab values.\n\n          -  Life expectancy of < 2 weeks.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Coumarin-type anticoagulants.\n\n          -  Oral hypoglycemics.\n\n          -  Barbiturates.\n\n          -  Phenytoin.\n\n          -  Immunostimulants.\n\n          -  Investigational drugs or approved (licensed) drugs for investigational indications\n             other than aerosolized pentamidine.\n\n        Prior Treatment:\n\n        Excluded:\n\n          -  Lymphocyte replacement."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002077", 
            "org_study_id": "012K", 
            "secondary_id": "056-164"
        }, 
        "intervention": {
            "intervention_name": "Fluconazole", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Fluconazole"
        }, 
        "keyword": [
            "AIDS-Related Opportunistic Infections", 
            "Meningitis", 
            "Injections, Intravenous", 
            "Cryptococcosis", 
            "Fluconazole", 
            "Administration, Oral", 
            "Acquired Immunodeficiency Syndrome"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Cook County Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07102"
                    }, 
                    "name": "Saint Michael's Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brooklyn", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11203"
                    }, 
                    "name": "SUNY / Health Sciences Ctr at Brooklyn"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10003"
                    }, 
                    "name": "Cabrini Med Ctr"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002077"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 1989"
    }, 
    "geocoordinates": {
        "Cabrini Med Ctr": "40.714 -74.006", 
        "Cook County Hosp": "41.878 -87.63", 
        "SUNY / Health Sciences Ctr at Brooklyn": "40.653 -73.959", 
        "Saint Michael's Med Ctr": "40.736 -74.172"
    }
}